Buscador de publicaciones

 
 
 
 
 

Mostrando 31 a 45 de 1563 publicaciones.

  • Arellano-Rodrigo E, Lopez-Vilchez I, Galán AM, Molina P, Reverter JC, Carne X, Villalta J, Tàssies D, Lozano M, Diaz-Ricart M, Escolar G. Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers. Transfus Med Rev 2015 Oct; 29(4): 242-9

    IF: 2.923, Cuartil: 2

    Ver abstract

  • Escudero P, Martinez de Marañón A, Collado A, Gonzalez-Navarro H, Hermenegildo C, Peiró C, Piqueras L, Sanz MJ. Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions. Antioxid. Redox Signal. 2015 Apr; 22(11): 901-20

    IF: 7.667, Cuartil: 1, Decil: 1

    Ver abstract

  • Ortiz-Pérez JT, Bosch X. Comments on exercise echocardiography and multidetector computed tomography for the evaluation of acute chest pain. Response. Rev Esp Cardiol (Engl Ed) 2015 Feb; 68(2): 165-6

    IF: 3.342, Cuartil: 2

    Ver abstract

  • Cequier A. Comments on the 2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) 2015 Feb; 68(2): 92-7

    IF: 3.342, Cuartil: 3

    Ver abstract

  • Rannikmäe K, Davies G, Thomson PA, Bevan S, Devan WJ, Falcone GJ, Traylor M, Anderson CD, Battey TW, Radmanesh F, Deka R, Woo JG, Martin LJ, Jiménez-Conde J, Selim M, Brown DL, Silliman SL, Kidwell CS, Montaner J, Langefeld CD, Slowik A, Hansen BM, Lindgren AG, Meschia JF, Fornage M, Bis JC, Debette S, Ikram MA, Longstreth WT, Schmidt R, Zhang CR, Yang Q, Sharma P, Kittner SJ, Mitchell BD, Holliday EG, Levi CR, Attia J, Rothwell PM, Poole DL, Boncoraglio GB, Psaty BM, Malik R, Rost N, Worrall BB, Dichgans M, Van Agtmael T, Woo D, Markus HS, Seshadri S, Rosand J, Sudlow CL. Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Neurology 2015 Mar; 84(9): 918-26

    IF: 8.303, Cuartil: 1, Decil: 1

    Ver abstract

  • Cid J, Molina JM, Mustieles MJ, Periáñez M, Lozano M. Comparison of plasma exchange procedures using three apheresis systems. Transfusion 2015 May; 55(5): 1001-7

    IF: 3.225, Cuartil: 2

    Ver abstract

  • Kiefer K, Carreras-Sureda A, García-López R, Rubio-Moscardo F, Casas J, Fabriàs G, Vicente R. Coordinated regulation of the orosomucoid-like gene family expression controls de novo ceramide synthesis in mammalian cells. J. Biol. Chem. 2015 Jan; 290(5): 2822-30

    IF: 4.6, Cuartil: 1

    Ver abstract

  • Barón Esquivias G, Escolar Albaladejo G, Zamorano JL, Betegón Nicolás L, Canal Fontcuberta C, de Salas-Cansado M, Rubio-Rodríguez D, Rubio-Terrés C. Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain. Rev Esp Cardiol (Engl Ed) 2015 Aug; 68(8): 680-90

    IF: 3.792, Cuartil: 2

    Ver abstract

  • Roldán Rabadán I, Anguita Sánchez M, Marín F, Quesada MA, Camacho Siles J, Peinado R, Bertomeu V, Cequier Fillat A, Badimon L, Muñiz J. Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry. Rev Esp Cardiol (Engl Ed) 2015 Jun;

    IF: 3.792, Cuartil: 2

    Ver abstract

  • Toral M, Gómez-Guzmán M, Jimenez R, Romero M, Zarzuelo MJ, Utrilla MP, Hermenegildo C, Cogolludo A, Perez-Vizcaino F, Gálvez J, Duarte J. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity. J. Hypertens. 2015 Sep; 33(9): 1831-44

    IF: 4.72, Cuartil: 1

    Ver abstract

  • Sotos-Prieto M, Moreno-Franco B, Ordovas JM, León M, Casasnovas JA, Peñalvo JL. Design and development of an instrument to measure overall lifestyle habits for epidemiological research: the Mediterranean Lifestyle (MEDLIFE) index. Public Health Nutr 2015 Apr; 18(6): 959-67

    IF: 2.679, Cuartil: 2

    Ver abstract

  • Rodríguez Campello A, Cuadrado Godia E, Giralt Steinhauer E, Rodríguez Fernández E, Dominguez A, Romeral G, Muñoz E, Roquer J. Detecting in-hospital stroke: Assessment of results from a training programme for medical personnel. Neurologia 2015 Sep; 30(9): 529-535

    IF: 1.352, Cuartil: 4

    Ver abstract

  • Núñez J, Bonanad C, Navarro JP, Bondanza L, Artero A, Ventura S, Núñez E, Miñana G, Sanchis J, Real J. Differential Effect of Glycosylated Hemoglobin Value and Antidiabetic Treatment on the Risk of 30-day Readmission Following a Hospitalization for Acute Heart Failure. Rev Esp Cardiol (Engl Ed) 2015 Oct; 68(10): 852-60

    IF: 3.342, Cuartil: 2

    Ver abstract

  • Escolar G, Carne X, Arellano-Rodrigo E. Dosing of rivaroxaban by indication: getting the right dose for the patient. Expert Opin Drug Metab Toxicol 2015; 11(10): 1665-77

    IF: 2.831, Cuartil: 2

    Ver abstract

  • de la Torre Hernández JM, Oteo Domínguez JF, Hernández F, Garcia Camarero T, Abdul-Jawad Altisent O, Rivero Crespo F, Cascón JD, Zavala G, Gimeno F, Arrebola Moreno AL, Andraka L, Gómez Menchero A, Bosa F, Carrillo X, Sánchez Recalde Á, Alfonso F, Perez de Prado A, López Palop R, Sanchis J, Diarte de Miguel JA, Jiménez Navarro M, Muñoz L, Ramírez Moreno A, Tizón Marcos H. Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2. Rev Esp Cardiol (Engl Ed) 2015 Oct; 68(10): 838-45

    IF: 3.792, Cuartil: 2

    Ver abstract

Una iniciativa de

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar